title: [Late complications of liver cirrhosis - management of gastrointestinal bleeding in the presence of portal hypertension].
abstract: Cirrhosis is the end stage of progressive development of different liver diseases and is associated with significant morbidity and mortality rates. Cirrhosis is associated with a number of potential complications, in particular with development of portal hypertension. Portal hypertension with the production of ascites, hepatic and gastric varices bleeding in the upper part of the gastrointestinal tract, presents the breakpoint in the natural course of cirrhosis, and it is associated with a considerably worse prognosis of patients, with a dramatically increased risk of mortality. A major progress was reached during the past 10-20 years in diagnosing liver cirrhosis (including non-invasive methods), in primary prevention of the initial episode of upper gastrointestinal bleeding and in the therapy of acute bleeding due to modern pharmacotherapy, with regard to expanding possibilities of therapeutic endoscopy and relatively new options for management of acute bleeding (esophageal stents, TIPS and suchlike). However acute upper gastrointestinal bleeding associated with portal hypertension still presents a considerable risk of premature death (15-20 %). Early diagnosing and causal treatment of numerous liver diseases may lead to slowing or regression of fibrosis and cirrhosis and possibly even of the degree of portal hypertension and thereby also the risk of bleeding.Key words: cirrhosis - esophageal varices - treatment of bleeding - portal hypertension.
authors.forename: Václav
authors.initials: V
authors.lastname: Hejda
mesh_terms: D000208:Acute Disease; D001201:Ascites / Q000209:etiology*; D004724:Endoscopy; D016145:Endoscopy, Digestive System; D004932:Esophageal and Gastric Varices / Q000209:etiology* / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology* / Q000628:therapy; D008103:Liver Cirrhosis / Q000150:complications*; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D015607:Stents